| |
 |
|
Elizabeth Thompson - President
As president, Elizabeth Thompson leads the organization’s efforts to save lives and end breast cancer forever by empowering people, ensuring quality care for all and energizing science to find the cures. Thompson is a highly respected leader in the global cancer community, recognized for her passion for driving innovation in science and medicine, and her expertise in formulating educational and public policy initiatives focused on quality and outcomes.
Read more
|
 |
|
Katrina McGhee - Exec. Vice President, Chief Marketing Officer
As executive vice president and chief marketing officer, Katrina McGhee is responsible for Komen’s global marketing, communications, events, multicultural marketing, new business strategies and cause marketing programs, along with oversight of more than 200 corporate partnerships, more than 140 Susan G. Komen Race for the Cure® Series events, millions of donors and more than $350 million in annual revenue.
Read more
|
| |
|
|
Mark E. Nadolny - Chief Financial Officer
As chief financial officer for Susan G. Komen for the Cure®, Mark E. Nadolny is responsible for all financial and administrative matters affecting the world’s largest breast cancer organization. Since inception, Komen for the Cure has invested more than $2.0 billion, making it the world’s largest source of private funds for breast cancer research and community programs involving awareness, education, screening, treatment and direct services for breast cancer.
Read more
|
|
|
Karen Handel - Senior Vice President, Public Policy
As senior vice president of public policy, Karen Handel is responsible for leading Susan G. Komen for the Cure® in its federal and state advocacy efforts. Her responsibilities include management of the Susan G. Komen for the Cure® Advocacy Alliance, the organization’s public policy arm.
Read more
|
|
|
Carol Corcoran - Senior Vice President, Affiliate Network
As Senior Vice President of the Affiliate Network, Carol Corcoran leads Susan G. Komen for the Cure’s unique network of more than 120 local Affiliates in the United States and internationally. Komen for the Cure’s Affiliate Network is the most extensive of any breast cancer organization, providing more than $1.3 billion to fund local screening, patient navigations, education and social and financial support to hundreds of thousands of people facing breast cancer in communities worldwide.
Read more
|
 |
|
Margo K. Lucero - Vice President, Business Development and Partnerships
As vice president, business development and partnerships for Susan G. Komen for the Cure®, Margo Lucero is responsible for directing a team that generates more then $50 million annually through cause related marketing and by developing philanthropic opportunities for strategic partnerships.
Read more
|
 |
|
Julie Teer - Vice President, Development
As vice president, development, Julie Teer serves as a key member of Susan G. Komen for the Cure®'s leadership team, contributing to strategic revenue decisions regarding the growth and cultivation of donor funds.
Read more
|
|
|
Katie Rohlman - Vice President, Human Resources
As vice president, human resources for Susan G. Komen for the Cure®, Katie Rohlman is responsible for attracting, retaining and developing the right people. She oversees the development, recommendation and promotion of comprehensive human resources policies and programs to achieve that goal.
Read more
|
 |
|
Nancy Macgregor - Vice President, Global Networks
Nancy Macgregor has been with Susan G. Komen for the Cure® for much of its history. As vice president, global networks, Macgregor collaborates with other Komen leadership members to develop, implement and evaluate strategies to build and sustain the capacity of the Komen Affiliate Network, which includes more than 120 Affiliates in the U.S. and three globally. Macgregor guides development and evaluation of pilot projects, benchmarks, standards of excellence and supporting resources to build and sustain the Affiliates’ capacity to fulfill Komen’s promise to save lives and end breast cancer forever. She also plays a key role in connecting Komen for the Cure’s U.S. Affiliate strategy to its international Affiliate strategy.
Read more
|
 |
|
David Dawson - Vice President, Information Technology
As vice president, information technology at Susan G. Komen for the Cure®, David Dawson leads the IT function of the world's largest breast cancer organization. Bringing his solid experience in IT leadership and notable passion for Komen for the Cure's mission to end breast cancer, Dawson ensures that the organization's IT function moves forward, strategically focused and operationally strong.
Read more
|
 |
|
Leslie Aun - Vice President, Marketing and Communications
As vice president of marketing and communications for Susan G. Komen for the Cure®, Leslie Aun oversees the strategic communications and integrated marketing activities of the world’s largest breast cancer organization. Her responsibilities include directing the organization’s public relations, branding, advertising, interactive marketing and event-planning teams.
Read more
|
 |
|
Chandini Portteus - Vice President, Research, Evaluation and Scientific Programs
As vice president, research, evaluation and scientific programs at Susan G. Komen for the Cure®, Chandini Portteus is responsible for the mission critical functions of research grant making, evaluation of mission impact and oversight of the organization's scientific advisory board and council.
Read more
|
| |
| |
 |
|
Diana Rowden - Survivorship & Outcomes Vice President
As survivorship and outcomes vice president for Susan G. Komen for the Cure®, Diana Rowden brings breadth and depth to her position, having served in a variety of leadership roles at Komen for the Cure for more than 15 years. Previously, Rowden was vice president of Komen’s Affiliate Network and oversaw its more than 120 Affiliates. She also led Komen's extensive health sciences division as vice president, overseeing the organization’s research grant strategy, community health outreach and education. She worked closely with the chief scientific advisor, Dr. Eric Winer, and Komen’s Scientific Advisory Board to examine medical and public health policy.
Read more
|
| |
